LFST LifeStance Health Group, Inc.
8-K Current Report
Filed: February 25, 2026
Health Care
Services-Health ServicesLifeStance Health Group, Inc. (LFST) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items4 items
- Item 2.02: Results of Operations and Financial Condition
- Item 5.02: Departure/Election of Directors or Officers
- Item 7.01: Regulation FD Disclosure
- Item 8.01: Other Events
AI Filing Analysis8-K
Item 2.02 · Results of Operations and Financial Condition
- • Q4 and full year 2025 earnings results released Feb 25, 2026
- • Full financial details in Exhibit 99.1 press release — key figures not disclosed in filing body
Item 5.02 · Departure/Election of Directors or Officers
- • Kenneth Burdick stepping down as Executive Chairman → non-executive Chairman effective March 16, 2026
- • Post-transition comp: $200K annual cash retainer + ~$500K annual RSU grant as non-executive chair
Item 7.01 · Regulation FD Disclosure
- • Supplemental slide deck filed as Exhibit 99.2 — primary source for any new operational or financial data disclosed under Reg FD
- • Reg FD filing ensures institutional and retail investors receive material information simultaneously — watch Exhibit 99.2 for guidance, metrics, or strategic updates
Item 8.01 · Other Events
- • Board approved $100M share repurchase program on Feb 24, 2026
- • No obligation to repurchase any specific amount — purely discretionary and open-ended
Other LifeStance Health Group, Inc. 8-K Filings
Get deeper insights on LifeStance Health Group, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.